[EN] COMPOUNDS FOR THE TREATMENT OF HCV<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DES INFECTIONS PAR VHC
申请人:BIOTA SCIENT MANAGEMENT
公开号:WO2013036994A1
公开(公告)日:2013-03-21
The present invention relates to viral polymerase inhibitors of formula (I), salts, solvates, hydrates, racemates, enatiomers and isomers thereof, in particular inhibitors of viral polymerases within the Flaviviridae family such as hepatitis C virus (HCV), processes for their preparation and their use in the treatment of Flaviviridae viral infection such as Hepatitis C virus (HCV) infections.
本发明涉及式(I)的病毒聚合酶抑制剂、其盐、溶剂化物、水合物、外消旋混合物、对映异构体和同分异构体,尤其是流感病毒科(Flaviviridae)内的病毒聚合酶抑制剂,如丙型肝炎病毒(HCV),其制备过程以及它们在治疗流感病毒科病毒感染,如丙型肝炎病毒(HCV)感染中的用途。